ArticleFrontiers in cellular neuroscience2024

5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy.

Shan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.